Načítá se...
Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action
BACKGROUND: Drug resistance is a cause of ovarian cancer recurrence and low overall survival rates. There is a need for more effective treatment approaches because the development of new drug is expensive and time consuming. Alternatively, the concept of ‘drug repurposing’ is promising. We focused o...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3922745/ https://ncbi.nlm.nih.gov/pubmed/24495391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-61 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|